Your browser doesn't support javascript.
loading
A Unique Presentation of 3-Methylcrotonyl-CoA Carboxylase Deficiency.
Jagadish, Ashwin; Sclater, Kaitlin; Lapinski, Taylor; Adkins, Karen; Selzer, Lauren.
Afiliação
  • Jagadish A; Pediatrics, East Tennessee State University James H. Quillen College of Medicine, Johnson City, USA.
  • Sclater K; Pediatrics, East Tennessee State University James H. Quillen College of Medicine, Johnson City, USA.
  • Lapinski T; Pediatrics, East Tennessee State University James H. Quillen College of Medicine, Johnson City, USA.
  • Adkins K; Pediatrics, East Tennessee State University James H. Quillen College of Medicine, Johnson City, USA.
  • Selzer L; Pediatrics, East Tennessee State University James H. Quillen College of Medicine, Johnson City, USA.
Cureus ; 15(5): e39401, 2023 May.
Article em En | MEDLINE | ID: mdl-37362523
ABSTRACT
3-methylcrotonyl-CoA carboxylase deficiency is an autosomal recessive disorder resulting in impaired leucine metabolism. The condition is typically diagnosed with newborn screening; patients diagnosed at a later stage generally present with symptoms including metabolic disturbances, seizures, failure to thrive, or delayed development. We present the case of a child diagnosed at 12 months of age who was noted to have recurrent viral infections and nonspecific gastrointestinal symptoms of vomiting, hematochezia, and gaseous distention of the abdomen. Newborn screening did not reveal any abnormalities. Evaluation for underlying immunodeficiency was unremarkable; genetic testing revealed bi-allelic mutations in MCCC2, a known association of 3-methylcrotonyl-CoA carboxylase deficiency. It is important to consider genetic disorders when evaluating patients even if the newborn screening is unremarkable.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article